- Home
- HOWL vs HOLO Comparison
HOWL vs HOLO Comparison
Compare HOWL & HOLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- HOLO
- Stock Information
- Founded
- HOWL 2017
- HOLO 2018
- Country
- HOWL United States
- HOLO China
- Employees
- HOWL N/A
- HOLO N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- HOLO Computer Software: Programming Data Processing
- Sector
- HOWL Health Care
- HOLO Technology
- Exchange
- HOWL Nasdaq
- HOLO Nasdaq
- Market Cap
- HOWL 37.9M
- HOLO N/A
- IPO Year
- HOWL 2021
- HOLO N/A
- Fundamental
- Price
- HOWL $0.87
- HOLO $7.76
- Analyst Decision
- HOWL Strong Buy
- HOLO
- Analyst Count
- HOWL 3
- HOLO 0
- Target Price
- HOWL $9.00
- HOLO N/A
- AVG Volume (30 Days)
- HOWL 232.7K
- HOLO 1.4M
- Earning Date
- HOWL 05-08-2025
- HOLO 01-01-0001
- Dividend Yield
- HOWL N/A
- HOLO N/A
- EPS Growth
- HOWL N/A
- HOLO N/A
- EPS
- HOWL N/A
- HOLO N/A
- Revenue
- HOWL $1,143,000.00
- HOLO $39,771,750.00
- Revenue This Year
- HOWL N/A
- HOLO N/A
- Revenue Next Year
- HOWL $733.33
- HOLO N/A
- P/E Ratio
- HOWL N/A
- HOLO N/A
- Revenue Growth
- HOWL N/A
- HOLO 42.62
- 52 Week Low
- HOWL $0.60
- HOLO $7.41
- 52 Week High
- HOWL $6.34
- HOLO $3,120.00
- Technical
- Relative Strength Index (RSI)
- HOWL 46.85
- HOLO 30.39
- Support Level
- HOWL $0.80
- HOLO $7.41
- Resistance Level
- HOWL $0.97
- HOLO $8.84
- Average True Range (ATR)
- HOWL 0.07
- HOLO 1.78
- MACD
- HOWL 0.02
- HOLO 0.41
- Stochastic Oscillator
- HOWL 41.92
- HOLO 3.82
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.